$CLX

Top Wall Street Forecasters Revamp Clorox Expectations Ahead Of Q4 Earnings - Clorox (NYSE:CLX)

Clorox (NYSE:CLX) is set to report Q4 earnings after the close on Aug. 3. Analysts expect EPS of $1.65 and revenue of $1.91B, versus $2.87 EPS and $1.99B revenue a year earlier, per Benzinga Pro. Clorox raised its quarterly dividend to $1.25 from $1.24. Shares fell 1.2% to $95.53 on Friday.

Original reporting
Published Aug 3, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 12:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Top Wall Street Forecasters Revamp Clorox Expectations Ahead Of Q4 Earnings - Clorox (NYSE:CLX) — source image
Decision brief

The 30-second read

$CLXNeutralMed
01

Why it matters

Traders can position for earnings volatility using the provided consensus EPS and revenue expectations, plus the noted dividend increase.

02

Market read

This is an earnings preview with consensus numbers and a small dividend increase, setting expectations for the after-close report.

03

What to watch

Actual results could diverge materially from consensus; the article does not include management commentary, margin drivers, or guidance changes that typically drive the post-earnings move.

Relevance 5/10Novelty 4/10Timing: ahead of Aug. 3 after-close Q4 earnings

Background

Clorox (CLX) is scheduled to release Q4 earnings after the close on Monday, Aug. 3.

Company-level read

Ticker impact

$CLXNeutralMedium confidence
Context

Clorox is set to report Q4 earnings after the close Aug. 3, with consensus EPS and revenue expectations cited.

Expected impact

Near-term volatility risk around the Aug. 3 after-close earnings release versus the stated consensus.

Evidence & confidence

Only consensus expectations ($1.65 EPS, $1.91B revenue) and a dividend raise ($1.24 to $1.25) are provided; no surprise or company-specific new forecast is disclosed.

Market effects

Limited signal for consumer staples broadly; the piece is primarily a single-name earnings setup.

No clear regional spillover beyond US large-cap staples earnings calendar.

Minimal, as the article contains no international demand, FX, or regulatory developments.

Counterpoint

The dividend hike may be interpreted as confidence in cash generation, potentially offsetting the year-over-year EPS decline implied by consensus.

Key entities

  • Clorox

    Subject of the article, scheduled to report Q4 earnings after the close Aug. 3 and raised its quarterly dividend to $1.25.

Related articles

$CLXMed

The Clorox Company Q4 2026 Earnings Call Summary

Clorox held its Q4 2026 earnings call, citing value-seeking consumer behavior and inflation pressures. Management said most categories have recovered from a prior cyberattack, with Litter still lagging. It highlighted GOJO acquisition synergies, fiscal 2027 assumptions including Brent at $90/bbl, inflation over $200M, and free cash flow of 11% to 13% of sales.

$CLXMedAI 8/10

Clorox fiscal 2027 outlook: inflation and value shoppers weigh

Clorox forecast a difficult fiscal 2027, citing inflation and consumers shifting to value. The company expects net sales up 13% to 14% for fiscal 2027, with about 9.5 points from its April 2026 GOJO Industries acquisition. Adjusted EPS is projected at $5.70 to $6.00, GAAP diluted EPS $5.41 to $5.71. Q4 revenue fell 2% to $1.95B; adjusted EPS was $1.66.

$CLXMedAI 8/10

Clorox forecasts upbeat annual sales as demand improves

Reuters reports Clorox (Pine-Sol maker) forecast fiscal 2027 net sales growth of 13% to 14%, above analysts’ 12.8% estimate, and adjusted EPS of $5.70 to $6 versus $5.97 expected. Q4 sales fell 2% to $1.95B but beat $1.90B. Gross margin dropped to 41.3%. Clorox cited improving demand amid a challenging cost and value-seeking environment.

$CLXMedAI 8/10

CLOROX CO /DE/ (CLX): Results of Operations and Financial Condition

CLOROX CO /DE/ (CLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-pressreleasedatedaug.htm EX-99.1 Document Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook Delivers Q4 results in line with expectations while advancing strategic investments OAKLAND, California, Aug. 3, 2026 — The Clorox Company (NYSE: CLX) today reporte

$CLXMedAI 9/10

Clorox Announces Leadership Transition as CEO Linda Rendle Prepares to Exit

The Wall Street Journal reported May 28 that Clorox CEO Linda Rendle will step down for health reasons after more than two decades. Clorox said it has started a comprehensive search for a new chief executive, while Rendle will remain in her role. In a blog post, Rendle said she was diagnosed with early-stage breast cancer, is now cancer-free, and cited ongoing treatment side effects.